Ribosome Stalling During Translation Presents Actionable Cancer Cell Vulnerability

Overview

Journal PNAS Nexus

Specialty General Medicine

Date 2024 Aug 20

PMID 39161732

Authors

Tejinder Pal Khaket

Suman Rimal

Xingjun Wang

Sunil Bhurtel

Yen-Chi Wu

Bingwei Lu

Affiliations

Soon will be listed here.

Abstract

Myc is a major driver of tumor initiation, progression, and maintenance. Up-regulation of Myc protein level rather than acquisition of neomorphic properties appears to underlie most Myc-driven cancers. Cellular mechanisms governing Myc expression remain incompletely defined. In this study, we show that ribosome-associated quality control (RQC) plays a critical role in maintaining Myc protein level. Ribosomes stall during the synthesis of the N-terminal portion of cMyc, generating aberrant cMyc species and necessitating deployment of the early RQC factor ZNF598 to handle translational stress and restore translation. ZNF598 expression is up-regulated in human glioblastoma (GBM), and its expression positively correlates with that of cMyc. ZNF598 knockdown inhibits human GBM neurosphere formation in cell culture and Myc-dependent tumor growth in vivo in . Intriguingly, the SARS-COV-2-encoded translational regulator Nsp1 impinges on ZNF598 to restrain cMyc translation and consequently cMyc-dependent cancer growth. Remarkably, Nsp1 exhibits synthetic toxicity with the translation and RQC-related factor ATP-binding cassette subfamily E member 1, which, despite its normally positive correlation with cMyc in cancer cells, is co-opted by Nsp1 to down-regulate cMyc and inhibit tumor growth. Ribosome stalling during translation thus offers actionable cancer cell vulnerability.

References

Sitron C, Brandman O . Detection and Degradation of Stalled Nascent Chains via Ribosome-Associated Quality Control. Annu Rev Biochem. 2020; 89:417-442. PMC: 8258965. DOI: 10.1146/annurev-biochem-013118-110729. View

Wu Z, Tantray I, Lim J, Chen S, Li Y, Davis Z . MISTERMINATE Mechanistically Links Mitochondrial Dysfunction with Proteostasis Failure. Mol Cell. 2019; 75(4):835-848.e8. PMC: 7362879. DOI: 10.1016/j.molcel.2019.06.031. View

Pelengaris S, Khan M, Evan G . Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 2002; 109(3):321-34. DOI: 10.1016/s0092-8674(02)00738-9. View

Dang C . MYC on the path to cancer. Cell. 2012; 149(1):22-35. PMC: 3345192. DOI: 10.1016/j.cell.2012.03.003. View

Sundaramoorthy E, Leonard M, Mak R, Liao J, Fulzele A, Bennett E . ZNF598 and RACK1 Regulate Mammalian Ribosome-Associated Quality Control Function by Mediating Regulatory 40S Ribosomal Ubiquitylation. Mol Cell. 2017; 65(4):751-760.e4. PMC: 5321136. DOI: 10.1016/j.molcel.2016.12.026. View

Brandman O, Hegde R . Ribosome-associated protein quality control. Nat Struct Mol Biol. 2016; 23(1):7-15. PMC: 4853245. DOI: 10.1038/nsmb.3147. View

Weng A, Millholland J, Yashiro-Ohtani Y, Arcangeli M, Lau A, Wai C . c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 2006; 20(15):2096-109. PMC: 1536060. DOI: 10.1101/gad.1450406. View

Kapur M, Monaghan C, Ackerman S . Regulation of mRNA Translation in Neurons-A Matter of Life and Death. Neuron. 2017; 96(3):616-637. PMC: 5693308. DOI: 10.1016/j.neuron.2017.09.057. View

Froldi F, Pachnis P, Szuperak M, Costas O, Fernando T, Gould A . Histidine is selectively required for the growth of Myc-dependent dedifferentiation tumours in the CNS. EMBO J. 2019; 38(7). PMC: 6443203. DOI: 10.15252/embj.201899895. View

10.

Karousis E, Schubert K, Ban N . Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective. EMBO J. 2024; 43(2):151-167. PMC: 10897431. DOI: 10.1038/s44318-023-00019-8. View

11.

Gregory M, Xiao Q, Cornwall G, Lutterbach B, Hann S . B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene. 2000; 19(42):4886-95. DOI: 10.1038/sj.onc.1203851. View

12.

Chu J, Hong N, Masuda C, Jenkins B, Nelms K, Goodnow C . A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc Natl Acad Sci U S A. 2009; 106(7):2097-103. PMC: 2650114. DOI: 10.1073/pnas.0812819106. View

13.

Meyer N, Penn L . Reflecting on 25 years with MYC. Nat Rev Cancer. 2008; 8(12):976-90. DOI: 10.1038/nrc2231. View

14.

Graber T, Hebert-Seropian S, Khoutorsky A, David A, Yewdell J, Lacaille J . Reactivation of stalled polyribosomes in synaptic plasticity. Proc Natl Acad Sci U S A. 2013; 110(40):16205-10. PMC: 3791775. DOI: 10.1073/pnas.1307747110. View

15.

Harigaya Y, Parker R . No-go decay: a quality control mechanism for RNA in translation. Wiley Interdiscip Rev RNA. 2011; 1(1):132-41. DOI: 10.1002/wrna.17. View

16.

Li J, Xie D . RACK1, a versatile hub in cancer. Oncogene. 2014; 34(15):1890-8. DOI: 10.1038/onc.2014.127. View

17.

Juszkiewicz S, Hegde R . Initiation of Quality Control during Poly(A) Translation Requires Site-Specific Ribosome Ubiquitination. Mol Cell. 2017; 65(4):743-750.e4. PMC: 5316413. DOI: 10.1016/j.molcel.2016.11.039. View

18.

Betschinger J, Mechtler K, Knoblich J . Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell. 2006; 124(6):1241-53. DOI: 10.1016/j.cell.2006.01.038. View

19.

Joazeiro C . Mechanisms and functions of ribosome-associated protein quality control. Nat Rev Mol Cell Biol. 2019; 20(6):368-383. PMC: 7138134. DOI: 10.1038/s41580-019-0118-2. View

20.

Asker C, Magnusson K, Piccoli S, Andersson K, Klein G, Cole M . Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region. Oncogene. 1995; 11(10):1963-9. View